UNAUDITED CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net (Loss) Income	$ (10,989,076)	$ (9,312,547)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	262,173	203,273
Amortization of operating lease right-of-use assets	16,137	18,887
Stock compensation expense	1,221,852	787,458
Loss of disposal of fixed assets	7,324	0
Amortization of debt discount	174,049	2,065,835
Change in fair value of derivative liabilities - convertible notes	111,150	(727,942)
Change in fair value of derivative liabilities - convertible warrants	(4,131,002)	(66,456)
Change in fair value of derivative liabilities - downside protection	0	3,033,820
Bad debt expense	0	10,981
Increase in notes payable due to default	255,080	0
Change in fair value of common stock payable	(123,230)	0
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(19,057)	4,024
Inventory	23,632	(98,184)
Accounts payable and accrued expenses	9,607,304	2,366,230
Interest payable to foundation	238,759	0
Loans from related parties	0	52,912
Refundable advance	2,000,000	0
Other current assets	(16,204)	(163,596)
Other current liabilities	25,423	(18,500)
Net cash used in operating activities	(1,335,538)	(1,843,805)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	0	(4,451)
Cash received in acquisition of a business, net of cash paid	0	49,305
Net cash provided by investing activities	0	44,854
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of notes payable	(60,000)	(935,731)
Proceeds from note payable	0	2,976,745
Proceeds from issuance of common stock	356,710	0
Proceeds from issuance of common stock and warrants in PIPE offering, net of fees of $150,000	1,850,000	0
Proceeds from exercise of warrants	9,144	0
Net cash provided by financing activities	2,155,854	2,041,014
Effects of currency translation on cash and cash equivalents	(2,202)	(294)
Net increase in cash and cash equivalents	818,114	241,769
Cash and cash equivalents, beginning of period	15,452	298,485
Cash and cash equivalents, end of period	833,566	540,254
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	50,000	25,000
Cash paid for taxes	0	0
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Reduction of derivative liabilities	538,084	1,911,487
Discount on derivative liability upon issuance of debt	1,472,826	1,052,349
Issuance of common stock for conversion of debt	1,127,840	1,694,851
Recording of right of use asset and liability	0	116,440
Increase common stock payable	0	14,500
Issuance of shares--common stock payable	0	921,895
Derivative liability in connection with issuance of warrants from PIPE offering	21,574,216	0
Settlement of derivative liability from exercise of warrants	$ 1,840,530